Suchergebnisse - "Sarilumab"

PubPharm (20)

1

Effectiveness and safety of sarilumab in patients with rheumatoid arthritis : A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry

enthalten in: Clinical rheumatology | 2024

von Harada, H. | Kondo, M. | Maeyama, A. | +8

ErratumIn: Clin Rheumatol. 2024 Mar 15;:. - PMID 38489137

2

Comparison of the efficacy and safety of tocilizumab, sarilumab, and olokizumab in patients with active rheumatoid arthritis : a network meta-analysis of randomized controlled trials

enthalten in: Zeitschrift fur Rheumatologie | 2024

von Ho Lee, Y. | Gyu Song, G.

3

Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis : results from post hoc analyses of three phase III trials of sarilumab

enthalten in: Arthritis research & therapy | 2022

von Rubbert-Roth, A. | Furst, D. | Fiore, S. | +5

4

Anti-Interleukin-6 Antibodies for Autoimmune Retinopathy with Macular Edema

enthalten in: Ophthalmology. Retina | 2022

von Deaner, J. | Jaffe, G. | Keenan, R. | +2

5

Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis : the ANSWER cohort study

enthalten in: Clinical rheumatology | 2021

von Ebina, K. | Hirano, T. | Maeda, Y. | +16

6

High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab

enthalten in: Arthritis research & therapy | 2020

von Strand, V. | Boklage, S. | Kimura, T. | +3

7

Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab

enthalten in: Infection | 2020

von Cingolani, A. | Tummolo, A. | Montemurro, G. | +39

8

Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020

von Sinha, P. | Mostaghim, A. | Bielick, C. | +15

9

Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID) : a structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Garcia-Vicuña, R. | Abad-Santos, F. | González-Alvaro, I. | +2

10

Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies

enthalten in: Arthritis research & therapy | 2020

von Genovese, M. | Fleischmann, R. | Kivitz, A. | +6